Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future
出版年份 2014 全文链接
标题
Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 78, Issue 4, Pages 699-706
出版商
Wiley
发表日期
2014-03-06
DOI
10.1111/bcp.12371
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeted Intraceptor Nanoparticle Therapy Reduces Angiogenesis and Fibrosis in Primate and Murine Macular Degeneration
- (2013) Ling Luo et al. ACS Nano
- Conversion to Aflibercept For Chronic Refractory Or Recurrent Neovascular Age-Related Macular Degeneration
- (2013) Yoshihiro Yonekawa et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
- (2013) Benjamin Bakall et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration
- (2013) Ilse Krebs et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration
- (2013) Adrienne W. Scott et al. CURRENT OPINION IN OPHTHALMOLOGY
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- Aflibercept for Age-Related Macular Degeneration: A Game-Changer or Quiet Addition?
- (2012) David J. Browning et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Novel Targets Against Retinal Angiogenesis in Diabetic Retinopathy
- (2012) Shuang Wang et al. Current Diabetes Reports
- Diverse roles for VEGF-A in the nervous system
- (2012) F. Mackenzie et al. DEVELOPMENT
- Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors
- (2012) Helen A. Mintz-Hittner EARLY HUMAN DEVELOPMENT
- The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease
- (2012) Hebah H. Al-Habboubi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- An Evidence-Based Meta-analysis of Vascular Endothelial Growth Factor Inhibition in Pediatric Retinal Diseases: Part 1. Retinopathy of Prematurity
- (2012) Mihai Mititelu et al. JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS
- Aflibercept
- (2012) Michael W. Stewart et al. NATURE REVIEWS DRUG DISCOVERY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
- (2012) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
- (2012) Usha Chakravarthy et al. OPHTHALMOLOGY
- Novartis takes legal action over trusts' advice to use bevacizumab for wet AMD
- (2012) I. Torjesen BMJ-British Medical Journal
- Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims File
- (2011) Ross J. Brechner et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity
- (2011) Tatsuhiko Sato et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development
- (2011) Diane C. Darland et al. DEVELOPMENTAL BIOLOGY
- Treatment-Related Mortality With Bevacizumab in Cancer Patients
- (2011) Vishal Ranpura et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
- (2010) Vishal Ranpura et al. ACTA ONCOLOGICA
- Causes of blind and partial sight certifications in England and Wales: April 2007–March 2008
- (2010) C Bunce et al. EYE
- Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model
- (2010) Jignesh J. Patel et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis
- (2010) Sanjaykumar Hapani et al. ONCOLOGY
- An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris
- (2009) M. Saint-Geniez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Predicted biological activity of intravitreal VEGF Trap
- (2008) M W Stewart et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Clinical pharmacokinetics of bevacizumab in patients with solid tumors
- (2008) Jian-Feng Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Vascular endothelial growth factor in eye disease
- (2008) J.S. Penn et al. PROGRESS IN RETINAL AND EYE RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started